The Roadmap

In the first episode in our mini-series on AI Governance, Vik Khurana and Simon McDougall set out how organisations can kick off their programme, starting with the important work of identifying and assessing the use of AI, risk framework maturity, roles and responsibilities and high level risk and regulatory exposure.

Send us Fan Mail

Note: All information was correct at the time of recording.

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn using #TheRoadmapPod

In this episode, Vik Khurana and Simon McDougall (Bristows Senior Adviser and Chief Strategist for AI at ZoomInfo) discuss the emerging discipline of AI governance and risk management. In particular they offer practical tips to those starting out in AI governance on:

• How to get started with setting up AI governance.
• The main industry frameworks and standards for useful baselines.
• Getting to know how your organisation engages with AI.

Here are links to the learning resources Simon and Vik discuss during the first section:

• Bristows AI resource centre
• Ada Lovelace Institute
• ICO AI resource centre
• Exponential View
• Silicon Sands
• AI as Normal Technology
• ISO/IEC 42001:2023
• NIST AI Risk Management Framework

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn to find more interesting content like this.

Note: All information was correct at the time of recording.

Send us Fan Mail

Note: All information was correct at the time of recording.

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn using #TheRoadmapPod

In this episode, Vik Khurana explains the ‘building blocks’ of an AI system and various legal and commercial trends, risks and issues. In particular:

• What are the building blocks?  A deep dive on training data, weights and parameters, model code, inference code and computational resources.  
• Where does value and IP reside within each block?  What is typically accessible and what is not?  What is proprietary and what is open sourced?
• The different licensing models and regulatory exceptions around the development and use of open source AI.

Here is a link to the ‘building blocks’ diagram Vik mentions in the episode that may be useful for listeners to view during the first half of the episode.

Send us Fan Mail

Note: All information was correct at the time of recording.

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn using #TheRoadmapPod

In this final episode of our three-part mini series on the EU AI Act and its implications for manufacturers of medical devices, Marc Dautlich and Alex Denoon look in detail at Annex V of the Act. 

Annex V of the EU AI Act requires, amongst other things, that a manufacturer provide the Notified Body making a conformity assessment with a statement that the high risk AI system that is being assessed and which forms part of the medical device, and which involves the processing of personal data (as many medical devices will), "complies with the GDPR". 

What exactly does a statement like that look like? And how are the Notified Bodies responsible for the conformity assessment going to evaluate the inevitable qualifications and caveats to any such statement that applicants are likely to make?

Send us Fan Mail

Note: All information was correct at the time of recording.

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn using #TheRoadmapPod

As rumours swirl of a delay to the date of application of the AI Act, here is part 2 of specialists Marc Dautlich and Alex Denoon's podcast.

In this episode, they delve further into Marc’s territory – the principles based GDPR - and note an uncomfortable practical constraint hidden away in Annex V of the EU AI Act.

This issue wasn’t addressed in Team-NB’s Position Paper, but is likely to be a significant challenge.

Send us Fan Mail

Note: All information was correct at the time of recording.

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn using #TheRoadmapPod

Team-NB, representing the majority of Notified Bodies for EU MDR and IVDR medical devices, has issued a stark warning: the implementation of the EU AI Act carries a significant risk of major disruption to the medical device software sector.

Their recently published Position Paper doesn't hold back, highlighting critical shortcomings in the implementation framework and emphasising the dwindling time left to address them. Team-NB is urgently calling for swift action to prevent widespread issues.

To unpack this crucial situation, our specialists Marc Dautlich and Alex Denoon offer their expert analysis of the Team-NB findings – and an additional key consideration – from the vantage points of data protection and product regulatory in this three part series.

Send us Fan Mail

Note: All information was correct at the time of recording.

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn using #TheRoadmapPod

In the second episode of our series exploring Corporate Law and AI, our experts, Partner Iain Redford (Corporate & Tax) and Partner Vik Khurana (Commercial Technology), highlight some of the key risks which are likely to arise in doing deals with the next generation of AI companies with suggestions about ways to mitigate those risks.

Note: All information was correct at the time of recording. (15.04.25)

Send us Fan Mail

Note: All information was correct at the time of recording.

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn using #TheRoadmapPod

In the first episode of our series exploring Corporate Law and AI, our experts, Partner Vik Khurana (Commercial Technology) and Of Counsel Richard Swaine (Corporate & Tax), focused on the current state of AI transactional work and recognising and protecting value.

Note: All information was correct at the time of recording. (14.03.25)

Send us Fan Mail

Note: All information was correct at the time of recording.

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn using #TheRoadmapPod

On this episode of The Roadmap, Alice Esuola-Grant and Jamie Cox discuss legislative updates in consumer technology as a result of the EU’s Product Liability Directive and the UK’s Digital Markets, Competition and Consumers Act.

They provide an overview of the new provisions, the timeline for implementing the new legislation and things that businesses should start thinking about now to ensure compliance.

Note: All information was correct at the time of recording.

Send us Fan Mail

Note: All information was correct at the time of recording.

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn using #TheRoadmapPod

In this episode, James Johnston and Anna Ni Uiginn talk about the EU NIS2 Directive which will raise cybersecurity standards across critical sectors in the EU. James and Anna will discuss the sectors that are within the scope of the directive, along with the new risk management measures and reporting requirements the directive introduces.

Note: All information was correct at the time of recording.

Send us Fan Mail

Note: All information was correct at the time of recording.

Thanks for listening!
If you have any feedback, questions or comments, please email us at [email protected]

Find all the episodes as we release them here, and don’t forget to subscribe! Follow us on LinkedIn using #TheRoadmapPod